Core Viewpoint - The pharmaceutical sector experienced a pullback in early trading, with various indices reflecting declines in the healthcare and pharmaceutical sectors in Hong Kong and mainland China [1][4][6][10][14]. Group 1: Index Performance - The Hang Seng Hong Kong Stock Connect Innovative Drug Index fell by 1.9% [1] - The CSI Hong Kong Stock Connect Pharmaceutical and Health Comprehensive Index decreased by 1.7% [1] - The CSI Innovative Drug Industry Index saw a decline of 0.3% [1] - The CSI Biotechnology Theme Index dropped by 0.2% [1] - The CSI 300 Pharmaceutical and Health Index experienced a slight decrease of 0.1% [1] Group 2: Fund Flows - The Pharmaceutical ETF (512010) recorded a net inflow of 400 million yuan over the past four trading days [1] - The Hang Seng Innovative Drug ETF (159316) attracted over 1.6 billion yuan in the past month [1]
医药板块集体回调，恒生创新药ETF（159316）、医药ETF（512010）受资金关注
Sou Hu Cai Jing·2025-11-07 05:02